The profit margin for TG Therapeutics decreased to 4.6% from 69% in 3Q 2023 due to higher expenses. Revenue exceeded estimates by 2.7%, but EPS missed by 28%.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
The profit margin for TG Therapeutics decreased to 4.6% from 69% in 3Q 2023 due to higher expenses. Revenue exceeded estimates by 2.7%, but EPS missed by 28%.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.